Selected research
Industry Research
Single Cell RNA Sequencing Service Industry Research Report 2026
Market perspective
The global Single Cell RNA Sequencing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Single Cell RNA Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Single Cell RNA Sequencing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Single Cell RNA Sequencing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Single Cell RNA Sequencing Service include BD, Admera Health, Novogene, BGI, SingleronBio, Active Motif, Thunder Bio, 10k Genomics and IQVIA Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Single Cell RNA Sequencing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Single Cell RNA Sequencing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Single Cell RNA Sequencing Service Market by Company
BD
Admera Health
Novogene
BGI
SingleronBio
Active Motif
Thunder Bio
10k Genomics
IQVIA Laboratories
Biomarker
Oxford Nanopore Technologies
M20 Genomics
Illumina
QIAGEN
Q2 Solutions
Novogene
Mission bio
PacBio
Azenta Life Sciences
Jingxin Biological
TaKaRa
Bio-Rad
Single Cell RNA Sequencing Service Segment by Type
Single-cell Transcriptome Sequencing
Single-cell Nuclear Transcriptome Sequencing
Single Cell RNA Sequencing Service Segment by Application
Cancer
Immunology
Neurology
Other
Single Cell RNA Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Cell RNA Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single Cell RNA Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Cell RNA Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Single Cell RNA Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-cell Transcriptome Sequencing
- Single-cell Nuclear Transcriptome Sequencing
Applications
- Cancer
- Immunology
- Neurology
- Other
Companies covered
- BD
- Admera Health
- Novogene
- BGI
- SingleronBio
- Active Motif
- Thunder Bio
- 10k Genomics
- IQVIA Laboratories
- Biomarker
- Oxford Nanopore Technologies
- M20 Genomics
- Illumina
- QIAGEN
- Q2 Solutions
- Novogene
- Mission bio
- PacBio
- Azenta Life Sciences
- Jingxin Biological
- TaKaRa
- Bio-Rad
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Single Cell RNA Sequencing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-cell Transcriptome Sequencing
- 2.2.3 Single-cell Nuclear Transcriptome Sequencing
- 2.3 Single Cell RNA Sequencing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer
- 2.3.3 Immunology
- 2.3.4 Neurology
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Single Cell RNA Sequencing Service Breakdown Data by Type
- 3.1 Global Single Cell RNA Sequencing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Single Cell RNA Sequencing Service Forecasted Market Size by Type (2027-2032)
4 Single Cell RNA Sequencing Service Breakdown Data by Application
- 4.1 Global Single Cell RNA Sequencing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Single Cell RNA Sequencing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Single Cell RNA Sequencing Service Market Perspective (2021-2032)
- 5.2 Global Single Cell RNA Sequencing Service Growth Trends by Region
- 5.2.1 Global Single Cell RNA Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Single Cell RNA Sequencing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Single Cell RNA Sequencing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Single Cell RNA Sequencing Service Market Dynamics
- 5.3.1 Single Cell RNA Sequencing Service Industry Trends
- 5.3.2 Single Cell RNA Sequencing Service Market Drivers
- 5.3.3 Single Cell RNA Sequencing Service Market Challenges
- 5.3.4 Single Cell RNA Sequencing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Single Cell RNA Sequencing Service Players by Revenue
- 6.1.1 Global Top Single Cell RNA Sequencing Service Players by Revenue (2021-2026)
- 6.1.2 Global Single Cell RNA Sequencing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Single Cell RNA Sequencing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Single Cell RNA Sequencing Service Head Office and Area Served
- 6.4 Global Single Cell RNA Sequencing Service Players, Product Type & Application
- 6.5 Global Single Cell RNA Sequencing Service Manufacturers Established Date
- 6.6 Global Single Cell RNA Sequencing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Single Cell RNA Sequencing Service Market Size (2021-2032)
- 7.2 North America Single Cell RNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Single Cell RNA Sequencing Service Market Size by Country (2021-2026)
- 7.4 North America Single Cell RNA Sequencing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Single Cell RNA Sequencing Service Market Size (2021-2032)
- 8.2 Europe Single Cell RNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Single Cell RNA Sequencing Service Market Size by Country (2021-2026)
- 8.4 Europe Single Cell RNA Sequencing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Single Cell RNA Sequencing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Single Cell RNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Single Cell RNA Sequencing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Single Cell RNA Sequencing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Single Cell RNA Sequencing Service Market Size (2021-2032)
- 10.2 South America Single Cell RNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Single Cell RNA Sequencing Service Market Size by Country (2021-2026)
- 10.4 South America Single Cell RNA Sequencing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Single Cell RNA Sequencing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Single Cell RNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Single Cell RNA Sequencing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Single Cell RNA Sequencing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BD
- 12.1.1 BD Company Information
- 12.1.2 BD Business Overview
- 12.1.3 BD Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.1.4 BD Single Cell RNA Sequencing Service Product Portfolio
- 12.1.5 BD Recent Developments
- 12.2 Admera Health
- 12.2.1 Admera Health Company Information
- 12.2.2 Admera Health Business Overview
- 12.2.3 Admera Health Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.2.4 Admera Health Single Cell RNA Sequencing Service Product Portfolio
- 12.2.5 Admera Health Recent Developments
- 12.3 Novogene
- 12.3.1 Novogene Company Information
- 12.3.2 Novogene Business Overview
- 12.3.3 Novogene Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.3.4 Novogene Single Cell RNA Sequencing Service Product Portfolio
- 12.3.5 Novogene Recent Developments
- 12.4 BGI
- 12.4.1 BGI Company Information
- 12.4.2 BGI Business Overview
- 12.4.3 BGI Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.4.4 BGI Single Cell RNA Sequencing Service Product Portfolio
- 12.4.5 BGI Recent Developments
- 12.5 SingleronBio
- 12.5.1 SingleronBio Company Information
- 12.5.2 SingleronBio Business Overview
- 12.5.3 SingleronBio Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.5.4 SingleronBio Single Cell RNA Sequencing Service Product Portfolio
- 12.5.5 SingleronBio Recent Developments
- 12.6 Active Motif
- 12.6.1 Active Motif Company Information
- 12.6.2 Active Motif Business Overview
- 12.6.3 Active Motif Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.6.4 Active Motif Single Cell RNA Sequencing Service Product Portfolio
- 12.6.5 Active Motif Recent Developments
- 12.7 Thunder Bio
- 12.7.1 Thunder Bio Company Information
- 12.7.2 Thunder Bio Business Overview
- 12.7.3 Thunder Bio Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.7.4 Thunder Bio Single Cell RNA Sequencing Service Product Portfolio
- 12.7.5 Thunder Bio Recent Developments
- 12.8 10k Genomics
- 12.8.1 10k Genomics Company Information
- 12.8.2 10k Genomics Business Overview
- 12.8.3 10k Genomics Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.8.4 10k Genomics Single Cell RNA Sequencing Service Product Portfolio
- 12.8.5 10k Genomics Recent Developments
- 12.9 IQVIA Laboratories
- 12.9.1 IQVIA Laboratories Company Information
- 12.9.2 IQVIA Laboratories Business Overview
- 12.9.3 IQVIA Laboratories Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.9.4 IQVIA Laboratories Single Cell RNA Sequencing Service Product Portfolio
- 12.9.5 IQVIA Laboratories Recent Developments
- 12.10 Biomarker
- 12.10.1 Biomarker Company Information
- 12.10.2 Biomarker Business Overview
- 12.10.3 Biomarker Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.10.4 Biomarker Single Cell RNA Sequencing Service Product Portfolio
- 12.10.5 Biomarker Recent Developments
- 12.11 Oxford Nanopore Technologies
- 12.11.1 Oxford Nanopore Technologies Company Information
- 12.11.2 Oxford Nanopore Technologies Business Overview
- 12.11.3 Oxford Nanopore Technologies Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.11.4 Oxford Nanopore Technologies Single Cell RNA Sequencing Service Product Portfolio
- 12.11.5 Oxford Nanopore Technologies Recent Developments
- 12.12 M20 Genomics
- 12.12.1 M20 Genomics Company Information
- 12.12.2 M20 Genomics Business Overview
- 12.12.3 M20 Genomics Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.12.4 M20 Genomics Single Cell RNA Sequencing Service Product Portfolio
- 12.12.5 M20 Genomics Recent Developments
- 12.13 Illumina
- 12.13.1 Illumina Company Information
- 12.13.2 Illumina Business Overview
- 12.13.3 Illumina Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.13.4 Illumina Single Cell RNA Sequencing Service Product Portfolio
- 12.13.5 Illumina Recent Developments
- 12.14 QIAGEN
- 12.14.1 QIAGEN Company Information
- 12.14.2 QIAGEN Business Overview
- 12.14.3 QIAGEN Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.14.4 QIAGEN Single Cell RNA Sequencing Service Product Portfolio
- 12.14.5 QIAGEN Recent Developments
- 12.15 Q2 Solutions
- 12.15.1 Q2 Solutions Company Information
- 12.15.2 Q2 Solutions Business Overview
- 12.15.3 Q2 Solutions Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.15.4 Q2 Solutions Single Cell RNA Sequencing Service Product Portfolio
- 12.15.5 Q2 Solutions Recent Developments
- 12.16 Novogene
- 12.16.1 Novogene Company Information
- 12.16.2 Novogene Business Overview
- 12.16.3 Novogene Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.16.4 Novogene Single Cell RNA Sequencing Service Product Portfolio
- 12.16.5 Novogene Recent Developments
- 12.17 Mission bio
- 12.17.1 Mission bio Company Information
- 12.17.2 Mission bio Business Overview
- 12.17.3 Mission bio Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.17.4 Mission bio Single Cell RNA Sequencing Service Product Portfolio
- 12.17.5 Mission bio Recent Developments
- 12.18 PacBio
- 12.18.1 PacBio Company Information
- 12.18.2 PacBio Business Overview
- 12.18.3 PacBio Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.18.4 PacBio Single Cell RNA Sequencing Service Product Portfolio
- 12.18.5 PacBio Recent Developments
- 12.19 Azenta Life Sciences
- 12.19.1 Azenta Life Sciences Company Information
- 12.19.2 Azenta Life Sciences Business Overview
- 12.19.3 Azenta Life Sciences Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.19.4 Azenta Life Sciences Single Cell RNA Sequencing Service Product Portfolio
- 12.19.5 Azenta Life Sciences Recent Developments
- 12.20 Jingxin Biological
- 12.20.1 Jingxin Biological Company Information
- 12.20.2 Jingxin Biological Business Overview
- 12.20.3 Jingxin Biological Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.20.4 Jingxin Biological Single Cell RNA Sequencing Service Product Portfolio
- 12.20.5 Jingxin Biological Recent Developments
- 12.21 TaKaRa
- 12.21.1 TaKaRa Company Information
- 12.21.2 TaKaRa Business Overview
- 12.21.3 TaKaRa Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.21.4 TaKaRa Single Cell RNA Sequencing Service Product Portfolio
- 12.21.5 TaKaRa Recent Developments
- 12.22 Bio-Rad
- 12.22.1 Bio-Rad Company Information
- 12.22.2 Bio-Rad Business Overview
- 12.22.3 Bio-Rad Revenue in Single Cell RNA Sequencing Service Business (2021-2026)
- 12.22.4 Bio-Rad Single Cell RNA Sequencing Service Product Portfolio
- 12.22.5 Bio-Rad Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst